External Counterpulsation Device Market

External counterpulsation is a non-invasive and medically proven treatment recommended for patients with angina or congestive heart failure condition. External counterpulsation is primarily preferred by patients to relieve discomfort and who are unresponsive to other treatments. External counterpulsation improves the circulation to the heart muscle, minimizes the heart workload, and boosts the flow of oxygen rich blood to the heart.
External Counterpulsation Device Market contains market size and forecasts of External Counterpulsation Device in global, including the following market information:
Global External Counterpulsation Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global External Counterpulsation Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five External Counterpulsation Device companies in 2021 (%)
The global External Counterpulsation Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adult ECP Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of External Counterpulsation Device include Applied Cardiac Systems, Cardiomedics, Renew Enhanced Circulation, VasoHealthcare, Advanced Life Sciences, Teleflex, Jarvik Heart, Medtronic and Biotronik and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the External Counterpulsation Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global External Counterpulsation Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global External Counterpulsation Device Market Segment Percentages, by Type, 2021 (%)
Adult ECP Device
Pediatric ECP Device
Global External Counterpulsation Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global External Counterpulsation Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Cardiac Centers/Clinics
Ambulatory Surgical Centers
Others
Global External Counterpulsation Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global External Counterpulsation Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies External Counterpulsation Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies External Counterpulsation Device revenues share in global market, 2021 (%)
Key companies External Counterpulsation Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies External Counterpulsation Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Applied Cardiac Systems
Cardiomedics
Renew Enhanced Circulation
VasoHealthcare
Advanced Life Sciences
Teleflex
Jarvik Heart
Medtronic
Biotronik
St. Jude Medical